Teva Pharmaceutical Industries Limited Announces Pricing of $2.5 Billion of Senior Notes

June 16, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) (“Teva”) announced today that it successfully priced the offering, by its special purpose finance subsidiaries, of a debt offering in three tranches:

Twitter
LinkedIn
Facebook
Email
Print

Asia